South Africa secures Europe-backed $90 million vaccine plant deal amid hantavirus outbreak fears, 7,000 jobs expected
South Africa has secured a Europe-backed $90 million deal to build Africa’s first fully integrated vaccine plant, a project expected to create over 7,000 jobs amid growing hantavirus outbreak fears. South Africa secured a R1.5 billion deal with the European Investment Bank and Biovac to build Africa’s first fully integrated end-to-end vaccine manufacturing plant. The…














